Fierce Pharma

OCTOBER 25, 2024

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem. | Iterum's Orlynvah was approved by the FDA Friday to treat certain uncomplicated urinary tract infections (uUTIs) in adult women who have limited or no alternative antibacterial treatment options.

FDA 307

FDA Medicine 307

MedCity News

OCTOBER 25, 2024

This week at HLTH, Dexcom COO Jake Leach discussed Stelo, his company’s new product. Stelo is an over-the-counter continuous glucose monitor meant for all adults who don’t take insulin. The post CGMs Aren’t Just for People with Diabetes Anymore, Dexcom COO Says appeared first on MedCity News.

Medical 126

Medical 126

Fierce Pharma

OCTOBER 25, 2024

Despite Merck & Co. | Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus antibody clesrovimab, Sanofi thinks Beyfortus can hold its own. On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more competition in the space is a net positive.

Competition 304

Competition Sales 304

MedCity News

OCTOBER 25, 2024

Septerna’s lead program is in Phase 1 testing for hypoparathyroidism. The therapies available and in development for this rare disease are injectable, and Septerna aims to stand apart with an oral GPCR-targeting small molecule. The post Septerna’s Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs appeared first on MedCity News.

Leads 119

Leads Biopharma Pharma 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

OCTOBER 25, 2024

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. | Johnson & Johnson tested Tremfya in patients with plaque psoriasis involvement in "sensitive or highly visible areas," while Lilly weighed Ebglyss in atopic dermatitis patients who've previously tried Dupixent.

Patients 304

Patients Competition Marketing 304

Pharmaceutical Technology

OCTOBER 25, 2024

At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

Pharma 115

Pharma 115

MedCity News

OCTOBER 25, 2024

How are employers tackling the current landscape of healthcare costs? We turned to Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, a group of regional coalitions representing self-insured employers large and small that cover roughly 40 million people. The post MedCity Pivot Podcast: Chat With Shawn Gremminger About Employer-Led Healthcare appeared first on MedCity News.

Healthcare 112

Healthcare Healthcare Insurance Biopharma 112

pharmaphorum

OCTOBER 25, 2024

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.The programme represents the largest capital spend by the UK drugmaker on production capacity to date and will double the size and capacity of GSK's existing medicines and vaccines facility in Marietta, Pennsylvania, creating around 200 new jobs.

Manufacturing 112

Manufacturing Networking Medicine 112

MedCity News

OCTOBER 25, 2024

A healthcare CRM is much more than a data management tool. It helps you make a strong first impression on each patient and strengthen relationships over time. The post The 3-Pronged Strategy to Boost Patient Engagement with Your CRM appeared first on MedCity News.

CRM 107

CRM Patients Healthcare Healthcare 107

pharmaphorum

OCTOBER 25, 2024

Intellia reports a big reduction in hereditary angioedema attacks in patients treated with its one-shot CRISPR drug, but its share fall sharply

Patients 111

Patients 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

OCTOBER 25, 2024

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

Manufacturing 98

Manufacturing 98

pharmaphorum

OCTOBER 25, 2024

MSD buys Modifi Bio in a $1.3bn deal, getting rights to a new class of drugs for difficult-to-treat cancers, including glioblastoma.

109

109

European Pharmaceutical Review

OCTOBER 25, 2024

New clinical data has shown a potential best-in-class next-generation antibody-drug conjugate (ADC) can offer promising response rates in extensive-stage small cell lung cancer. The biologic ZL-1310 is being investigated in an ongoing Phase Ia/Ib study in these patients who have had at least one platinum-based chemotherapy regimen. Overall response rate was 74 percent in individuals with at least one post-treatment evaluation.

Patients 97

Patients Medical Pharmaceutical 97

pharmaphorum

OCTOBER 25, 2024

NICE backs two AI algorithms from Boston Scientific and Medtronic for monitoring heart failure patients, but turns down others from Biotronik and Abbott.

Patients 72

Patients 72

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

OCTOBER 25, 2024

What are hospitals trying to say with color today? Is it working? Maybe it’s not actually what patients want. And with that in mind, how might we build a more colorful future that changes this dynamic? The post Can Color Impact Healthcare Culture? appeared first on MedCity News.

Healthcare 69

Healthcare Healthcare Patients 69

Pharmaceutical Commerce

OCTOBER 25, 2024

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

Management 64

Management Medical Patients 64

Healthcare Success

OCTOBER 25, 2024

Despite the influx of digital technologies into virtually every aspect of our everyday lives, healthcare is still a very human business. As a result, healthcare providers still heavily rely on positive relationships with their referring doctors and other healthcare professionals (HCPs). While leading health systems and hospitals have long employed teams of on-the-ground “physician liaisons” to protect and grow their vital referral sources, today leading multilocation specialty practices do the s

Physicians 62

Physicians Doctors Sales Marketing 62

PharmaTech

OCTOBER 25, 2024

The laboratory is on the same site as BioDuro-Sundia’s new Compound Management Center, which was launched earlier in October 2024.

Management 59

Management 59

Advertisement

Pharmaceutical Technology

OCTOBER 25, 2024

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.

59

59

Pharmaceutical Commerce

OCTOBER 25, 2024

The latest news for pharma industry insiders.

Pharma 59

Pharma Medical 59

Pharmaceutical Technology

OCTOBER 25, 2024

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with fibrostenosing Crohn’s disease.

Patients 59

Patients 59

Pharmacy Times

OCTOBER 25, 2024

Their expertise complements multidisciplinary teams in a variety of clinical settings.

58

58

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

OCTOBER 25, 2024

Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at decarbonisation across the healthcare ecosystem.

Healthcare 59

Healthcare Healthcare Medical 59

Pharmacy Times

OCTOBER 25, 2024

Pharmacists are encouraged to leverage prescription drug monitoring programs connect patients to community-based resources to address the opioid crisis and pharmacy deserts.

Patients 55

Patients Prescription 55

Pharma Marketing Network

OCTOBER 25, 2024

In an era wher Pharmaceutical digital marketing is in the middle of a rapid transformation. For pharma marketing executives , reaching audiences in meaningful, personalized ways has never been more critical. But with complex regulations, fast-evolving digital tools, and the challenges of building trust, it’s tough to know where to start. In this guide, we’ll break down the essentials of pharmaceutical digital marketing to help you navigate the unique challenges of the industry and maximize your

Marketing 52

Marketing Pharmaceutical Pharma Healthcare Provider 52

Pharmacy Times

OCTOBER 25, 2024

The call follows the FDA’s sudden removal of tirzepatide from the drug shortage list, preventing compounding pharmacies from providing the drug.

FDA 52

FDA 52

Advertisement

Distribution

PharmaTech

OCTOBER 25, 2024

The report highlights international regulators’ plans for the development and availability of vaccines to prevent and drugs to treat mpox.

52

52

Pharmacy Times

OCTOBER 25, 2024

Orlynvah is approved for uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.

FDA 52

FDA 52

PharmExec

OCTOBER 25, 2024

Under terms of the deal, Richter will receive an upfront cash payment of $25 million, along with potential future development, regulatory, and commercialization milestones.

52

52

Pharmacy Times

OCTOBER 25, 2024

Congenital muscular dystrophy type 1a is a severe, early-onset condition that currently has no treatment, but MDL-101 may serve as a 1-time, durable treatment option.

FDA 52

FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales